Aesthetic and regenerative oral plastic surgery: clinical applications in tissue engineering.
Nevins
Marc L
ML
Department of Periodontology, Harvard School of Dental Medicine, USA. marc_nevins@hms.harvard.edu
D016301:Alveolar Bone Loss / Q000601:surgery; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000077214:Becaplermin; D018786:Bone Substitutes / Q000627:therapeutic use; D016025:Bone Transplantation / Q000379:methods; D002130:Calcium Phosphates / Q000627:therapeutic use; D003238:Connective Tissue / Q000637:transplantation; D003746:Dental Enamel Proteins / Q000627:therapeutic use; D004955:Esthetics, Dental; D005260:Female; D005500:Follow-Up Studies; D017823:Furcation Defects / Q000601:surgery; D005881:Gingiva / Q000637:transplantation; D005889:Gingival Recession / Q000601:surgery; D016557:Guided Tissue Regeneration, Periodontal / Q000379:methods*; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D016745:Root Planing / Q000379:methods; D013752:Tetracycline / Q000627:therapeutic use; D023822:Tissue Engineering
D000900:Anti-Bacterial Agents; D018786:Bone Substitutes; D002130:Calcium Phosphates; D003746:Dental Enamel Proteins; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; C485817:beta-tricalcium phosphate; C109069:enamel matrix proteins; D000077214:Becaplermin; D013752:Tetracycline